H. Egli

937 total citations
71 papers, 568 citations indexed

About

H. Egli is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, H. Egli has authored 71 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 10 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in H. Egli's work include Hemophilia Treatment and Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Platelet Disorders and Treatments (9 papers). H. Egli is often cited by papers focused on Hemophilia Treatment and Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Platelet Disorders and Treatments (9 papers). H. Egli collaborates with scholars based in Germany, United States and Switzerland. H. Egli's co-authors include Ulrich Budde, G. Bradley Schaefer, Nicolas J. Mueller, Peter Hanfland, R.G. Kladetzky, K. Olek, Werner Kördel, K. Andrássy, Michael Klein and R. Egbring and has published in prestigious journals such as Blood, Journal of Agricultural and Food Chemistry and Pure and Applied Chemistry.

In The Last Decade

H. Egli

59 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Egli Germany 13 276 128 128 69 62 71 568
Michael G. Chen United States 14 146 0.5× 415 3.2× 159 1.2× 55 0.8× 82 1.3× 25 930
Bruce Buddington United States 8 60 0.2× 42 0.3× 34 0.3× 76 1.1× 31 0.5× 8 561
M. T. Smith United Kingdom 5 192 0.7× 238 1.9× 73 0.6× 46 0.7× 14 0.2× 8 568
Galina Shamayeva United States 9 344 1.2× 60 0.5× 205 1.6× 76 1.1× 53 0.9× 16 549
Claudette Bethune United States 12 323 1.2× 134 1.0× 374 2.9× 21 0.3× 57 0.9× 20 812
Larry M. Allen United States 15 93 0.3× 300 2.3× 43 0.3× 45 0.7× 44 0.7× 38 642
Shigeru Okada Japan 14 86 0.3× 171 1.3× 66 0.5× 70 1.0× 139 2.2× 24 756
Gajalakshmi Ramanathan United States 13 88 0.3× 102 0.8× 104 0.8× 38 0.6× 16 0.3× 24 434
Silvia de la Iglesia Spain 11 139 0.5× 108 0.8× 160 1.3× 19 0.3× 13 0.2× 34 331
Gudrun Windbichler Austria 16 69 0.3× 233 1.8× 19 0.1× 135 2.0× 54 0.9× 27 1.0k

Countries citing papers authored by H. Egli

Since Specialization
Citations

This map shows the geographic impact of H. Egli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Egli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Egli more than expected).

Fields of papers citing papers by H. Egli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Egli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Egli. The network helps show where H. Egli may publish in the future.

Co-authorship network of co-authors of H. Egli

This figure shows the co-authorship network connecting the top 25 collaborators of H. Egli. A scholar is included among the top collaborators of H. Egli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Egli. H. Egli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwaab, R., Michael Ludwig, Johannes Oldenburg, et al.. (1991). Detection and characterisation of two missense mutations at a cleavage site in the factor VIII light chain. Thrombosis Research. 61(3). 225–234. 12 indexed citations
2.
Iwanzik, W. & H. Egli. (1989). Comparison of bioassay and chemical analysis for triasulfuron quantification in soil samples.. 3. 1145–1150. 2 indexed citations
3.
Ludwig, Michael, et al.. (1988). Haemophilia B+ with Inhibitor. Thrombosis and Haemostasis. 59(2). 340–340. 7 indexed citations
4.
Schwaab, R., Johannes Oldenburg, Miyoko Higuchi, et al.. (1988). Haemophilia A: Carrier detection by DNA analysis. Annals of Hematology. 57(2). 85–90. 4 indexed citations
5.
Egli, H.. (1982). Das Schlangensymbol : Geschichte, Märchen, Mythos. 1 indexed citations
6.
Egli, H.. (1981). The situation of the haemophiliac: yesterday and today.. PubMed. 10 Suppl 1. 1–10. 3 indexed citations
7.
Egli, H., et al.. (1979). Triazine herbicide residues in central European streams.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 13(3). 128–31. 22 indexed citations
8.
Hanfland, Peter, R.G. Kladetzky, & H. Egli. (1978). Isolation and purification of Lea blood-group active and related glycolipids from human plasma of blood-group A Lea individuals. Chemistry and Physics of Lipids. 22(2). 141–151. 15 indexed citations
9.
Egli, H., et al.. (1975). Diagnostic criteria and long term therapy of bleeding disorders in von Willebrand's disease. Thrombosis Research. 6(2). 119–125. 2 indexed citations
10.
Hanfland, Peter & H. Egli. (1975). Quantitative Isolation and Purification of Blood Group‐Active Glycosphingolipids from Human B Erythrocytes. Vox Sanguinis. 28(6). 438–452. 28 indexed citations
11.
Egli, H., et al.. (1971). Zur Traumatisierung des Blutes bei einem Vergleich dreier gebräuchlicher Entnahmemethoden zur Gewinnung von Konservenblut. Annals of Hematology. 22(2). 53–59. 2 indexed citations
12.
Egbring, R., et al.. (1971). Diagnostische und therapeutische Probleme bei congenitaler Afibrinogenämie. Annals of Hematology. 22(4). 175–201. 12 indexed citations
13.
Andrássy, K., et al.. (1971). [Plasma transglutaminase activity in congenital total and partial factor XIII deficiency (a contribution to the problem of factor XIII determination)].. PubMed. 25(1). 166–77. 3 indexed citations
14.
Egbring, R., et al.. (1970). [2 patients with congenital factor XIII deficiency. Contribution to the problem of factor XIII determination].. PubMed. 23(2). 313–39. 9 indexed citations
15.
Schneider, W, et al.. (1961). [On the behavior of the Hageman factor and plasma thromboplastin antecedent (PTA) under the influence of hydroxycoumarin and phenylindanedione administration].. PubMed. 5. 595–6.
16.
Egli, H., et al.. (1960). Gerinnungsphysiologische Untersuchungen und Leberfunktion1. DMW - Deutsche Medizinische Wochenschrift. 85(9). 350–355. 5 indexed citations
17.
Egli, H., et al.. (1958). [Studies on blood coagulation during & after physical work].. PubMed. 17(3). 228–42. 1 indexed citations
18.
Egli, H.. (1957). Untersuchungen zur Bildung der Blutthrombokinase. Pflügers Archiv - European Journal of Physiology. 266(1). 11–11. 1 indexed citations
19.
Egli, H., et al.. (1957). Über die Einwirkung körperlicher Arbeit auf die Blutgerinnung. Pflügers Archiv - European Journal of Physiology. 266(1). 10–11. 4 indexed citations
20.
Egli, H., et al.. (1956). Über die Anwendung der Plasmafraktion I bei unstillbaren Blutungen1. DMW - Deutsche Medizinische Wochenschrift. 81(22). 875–876. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026